Pricing Log in Create free account

Fractyl Health, Inc. (GUTS) vs Rein Therapeutics Inc. (RNTX)

Fractyl Health, Inc. and Rein Therapeutics Inc. are both Biotechnology companies. Fractyl Health, Inc. and Rein Therapeutics Inc. are of similar size ($55.2M and $54.2M). Across the 9 metrics below, Fractyl Health, Inc. leads on 5 and Rein Therapeutics Inc. on 4.

Valuation

Metric GUTS RNTX Biotechnology median
P/E n/m n/m 8.50
P/S 2,644.15 n/m 9.71
P/B n/m 3.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.03 0.64
EV/Sales 2,464.64 n/m 9.21
Earnings yield (56.77%) (291.53%) (33.15%)
Free cash flow yield (33.75%) (47.32%) (25.50%)

Profitability

Metric GUTS RNTX Biotechnology median
Gross margin 46.24% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,063.04% (753.55%) (56.36%)
Return on assets (146.75%) (80.62%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS RNTX Biotechnology median
Revenue growth (TTM) (22.50%) — 6.02%
EPS growth (last fiscal year) (14.81%) 44.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS RNTX Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 4.27 4.72
Net debt to EBITDA 0.53 0.15 0.96

Dividend

Metric GUTS RNTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GUTS RNTX Biotechnology median
Market cap 55.18m 54.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack